Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Headwork as innovative tool for monitoring MABs efficacy in migraine and their influence on work activity

Author:Montisano, Danilo Antonio   Vaghi, Gloria   Raggi, Alberto   Sances, Grazia   Tassorelli, Cristina   Grazzi, Licia   

Session Name:P12: Headache: Towards Precision Medicine 2  

Topic:Headache  

Program Number:P12.010  

Author Institution:University of Milano Bicocca, Milano, Italy  IRCCS Mondino Foundation, Pavia, Pavia, Italy  Neurological Institute C Besta, Milan, Italy  

Results from 96 Weeks Open-Label Extension of a Phase 2 Trial of Losmapimod in Subjects with FSHD: ReDUX4

Author:Wang, Leo   Han, Jay   Shoskes, Jennifer   Jiang, John   Tawil, Alrabi   

Session Name:S48: Therapeutics for Muscle Disease  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S48.008  

Author Institution:University of Washington, Seattle, WA  UCI Medical Center, Orange, CA  Fulcrum Therapeutics, Cambridge, MA  University of Rochester Medical Center, Rochester, NY  

Annualized Rates of Change from A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of Losmapimod in Subjects with FSHD: ReDUX4

Author:Tawil, Alrabi   

Session Name:S48: Therapeutics for Muscle Disease  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S48.010  

Author Institution:University of Rochester Medical Center, Rochester, NY  

Investigating the Risk of Hypertension After Initiation of Erenumab in the Post-Market Setting

Author:Chhabra, Nikita   Mead-Harvey, Carolyn   Iser, Courtney   Taylor, Hallie   Chaudhary, Hira   Vanood, Aimen   Dodick, David   

Session Name:S47: Advances in Migraine Therapeutics  

Topic:Headache  

Program Number:S47.009  

Author Institution:Mayo Clinic, Scottsdale , AZ  Mercy Clinic, Oklahoma City, OK  

Case Series of Nitrous Oxide Related Subacute Combined Degeneration from 2016 to 2022

Author:Warren, William   Taylor, Reid   Savage, Jennie   

Session Name:P9: General Neurology: Deficiency and Toxicity  

Topic:General Neurology  

Program Number:P9.002  

Author Institution:MAHEC, Asheville, NC  Mission Neurology Services, Asheville, NC  Mission Neurology, Asheville, NC